| Top Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Legal > Cyber Law > How to Assign Copyrights for an eBook to a Non-Profit; Sample Letter |
|
Top Articles - How to Assign Copyrights for an eBook to a Non-Profit; Sample Letter
If you are an author and have written an e-book, which can help people often nonprofit groups will discover it and ask if According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product they can put the e-book on their web site for all their members of their organization. Some authors don't want to do this ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in because they want to make money selling the e-book online and make 50% royalties. Although if you're a prolific online e lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. -book writer then you know you have plenty of other parks to make money on and this is something you can do for the common here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe good. Below is a sample letter that I use when I give the rights to reprint my book to a nonprofit organization for thei d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro r web site or so they can run off copies to their members. Perhaps this might come in handy and or give you ideas on ways ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc to give a little back to the rest of the world. Please consider this in 2006; below is a copy of the letter: (Date) Na easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi me of Publishing Company Or Nonprofit Group Dear (Name of Person), This letter will confirm our phone conversation of (D nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ate of Phone Call) giving you and your company permission to copy, modify, and distribute my book “(Name of Book), as long and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ as you give me credit for the work. ie: authored by (Your Name Here) on the cover of the actual work itself. I would als ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi request that you leave my Bio somewhere in the work so the readers will know that this was written by a real person with ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a over 20 years experience in the industry. My intention is not to make money on this work, but rather to insure all of my dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod experiences be passed on to others who may benefit in their non-profit groups by learning the techniques listed in my book cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin . I realize that you wish to distribute this book to (Name of Organization) and that certain changes must be made in this tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen book to accommodate that audience. This is fine with me. Please your best judgment to improve on the book’s diction, sy t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ntax, paragraph structure and political commentary, as we are all just trying to (State Your Purpose in Writing the Book). ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust I understand you will be doing this editing for your distribution to the (Name of Organizations and Some Organizations y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products or Web Site) as well as distribution to other groups, government agencies and school systems for the same purpose of helpi . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ng people (Mention Their Purpose). I’m glad to help you and the (Name of Organization) and (Organization Basic Mission). elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip Good luck and call me if you have any questions. (Your Name and Phone Number Here) Sincerely, (Your Name) (Your Title tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:List Building With Joint Ventures Is a Number One Position the SEO Holy Grail Lead Generation#5 - Why Competition Will Create Profits On-Line
|